Chronic Pain — Chronic Pain in Patients in Hemodialysis
Citation(s)
Arregger AL, Cardoso EM, Tumilasci O, Contreras LN Diagnostic value of salivary cortisol in end stage renal disease. Steroids. 2008 Jan;73(1):77-82. doi: 10.1016/j.steroids.2007.09.001. Epub 2007 Sep 11.
Cohen SP, Vase L, Hooten WM Chronic pain: an update on burden, best practices, and new advances. Lancet. 2021 May 29;397(10289):2082-2097. doi: 10.1016/S0140-6736(21)00393-7.
Coluzzi F Assessing and Treating Chronic Pain in Patients with End-Stage Renal Disease. Drugs. 2018 Sep;78(14):1459-1479. doi: 10.1007/s40265-018-0980-9.
Hylands-White N, Duarte RV, Raphael JH An overview of treatment approaches for chronic pain management. Rheumatol Int. 2017 Jan;37(1):29-42. doi: 10.1007/s00296-016-3481-8. Epub 2016 Apr 23.
Luque-Suarez A, Martinez-Calderon J, Falla D Role of kinesiophobia on pain, disability and quality of life in people suffering from chronic musculoskeletal pain: a systematic review. Br J Sports Med. 2019 May;53(9):554-559. doi: 10.1136/bjsports-2017-098673. Epub 2018 Apr 17.
Meuwese CL, Carrero JJ Chronic kidney disease and hypothalamic-pituitary axis dysfunction: the chicken or the egg? Arch Med Res. 2013 Nov;44(8):591-600. doi: 10.1016/j.arcmed.2013.10.009. Epub 2013 Nov 8.
Raina R, Krishnappa V, Gupta M Management of pain in end-stage renal disease patients: Short review. Hemodial Int. 2018 Jul;22(3):290-296. doi: 10.1111/hdi.12622. Epub 2017 Dec 11.
Reyes del Paso GA, Perales Montilla CM Haemodialysis course is associated to changes in pain threshold and in the relations between arterial pressure and pain. Nefrologia. 2011;31(6):738-42. doi: 10.3265/Nefrologia.pre2011.Oct.10902. English, Spanish.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
